aspirin

Impact of aspirin in reducing preterm preeclampsiaA study looks at the efficacy of aspirin in reducing preterm preeclampsia. Plus: The CDC reports on antidepressant use in the United States. Also, a look at whether vaginal estrogen postmenopause increases the risk of heart disease and certain types of cancer.
Aspirin to prevent preeclampsia: When to start and how much to give?Aspirin had been used as a way to cure preeclampsia, but then evidence-based studies clouded whether it actually helped. Two recent trials have provided encouraging data on use of low-dose aspirin in treating preeclampsia.
Small Doses: Pharmacy News Featuring Vaccine Skeptics, an Aspirin-Cancer Link, and More
Small Doses: Pharmacy News Featuring Vaccine Skeptics, an Aspirin-Cancer Link, and MoreEasy-to-swallow bits of news from around the world of pharmacy.
Prevent polypharmacy problemsPolypharmacy presents real problems—especially for older adults.
USPSTF updates recommendations for aspirin useThe guidelines, which update the group's 2007 and 2009 recommendations, are published in the "Annals of Internal Medicine."
Unusual abdominal pain in an 8-year-old boyA previously healthy 8-year-old Hispanic boy presented to the emergency department (ED) with a 2-day history of abdominal pain and 2 episodes of nonprojectile vomiting in the last 24 hours.
Limb gangrene in cancer patients receiving warfarinVenous limb gangrene can occur in cancer patients, but the clinical picture and pathogenesis aren’t clear.
Aspirin recommended to prevent CVD, colorectal cancerAspirin should be taken daily in low doses by certain people to not only prevent heart disease and stroke, but also colon cancer, according to new draft guidelines.
New aspirin formulation approved for secondary prevention of stroke, cardiac eventsFDA approved aspirin extended release capsules (Durlaza, New Haven Pharmaceuticals, Inc.) for the prevention of stroke and acute cardiac events.
PCORI approves trial to determine best aspirin dose to help heart disease patientsThe Patient-Centered Outcomes Research Institute (PCORI) Board of Governors this week approved a 3-year, $14 million clinical trial designed to determine the best dose of aspirin to use to prevent heart attacks and strokes in people with heart disease.